Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Christianson currently holds 214,283 shares of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Christianson has been a net seller of NMTC stock. They have purchased $0 and sold $530.4K worth of shares.
Mark Christianson's most recent insider trade was on Mar 13, 2026, when they sold 100 shares at $0.80 per share.
Mark Christianson serves as Executive at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC). They have executed 46 insider transactions totaling $530.4K over their tenure at the company.
Mark Christianson holds the position of Executive at NEUROONE MEDICAL TECHNOLOGIES Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Mark Christianson has shown a selling trading pattern, with $0 in total purchases and $530.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Christianson was on Jun 12, 2020, when they sold $200.4K worth of NMTC shares. This transaction involved 334,000 shares at $0.60 per share.
Mark Christianson currently owns 214,283 shares of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Christianson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Christianson has 46 Form 4 filings on record as an insider at NEUROONE MEDICAL TECHNOLOGIES Corp.
Set alerts for Mark Christianson and 40,000+ other insiders.